CAS号:877399-52-5
品名:克唑替尼Crizotinib
中文别名:克里唑替尼;克里唑啼尼;3-[(1R)-1-(2,6-二氯-3-氟苯基)乙氧基]-5-[1-(4-哌啶)-1H-吡唑-4-基]-2-吡啶胺;3-[(R)-1-(2,6-二氯-3-氟苯基)乙氧基]-5-[1-(哌啶-4-基)-1H-吡唑-4-基]吡啶-2-胺;
英文别名:(R)-Crizotinib;Xalkori;3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine;
分子式:C21H22Cl2FN5O
分子量:450.337
精确质量:449.119
Psa:77.99
MDL号:MFCD12407409
密度:1.475g/cm3
沸点:599.177ºC at 760 mmHg
闪点:316.171ºC
折射率:1.673
海关编码:2933990090
信号词:Warning
危险性防范说明:P273; P280; P305 + P351 + P338
危险标志:GHS07, GHS08, GHS09
危险性描述:H317; H319; H341; H400
简介:Crizotinib(tradenameXalkori,Pfizer)isananti-cancerdrugactingasanALK(anaplasticlymphomakinase)andROS1(c-rosoncogene1)inhibitor,approvedfortreatmentofsomenon-smallcelllungcarcinoma(NSCLC)intheUSandsomeothercountries,andundergoingclinicaltrialstestingitssafetyandefficacyinanaplasticlargecelllymphoma,neuroblastoma,andotheradvancedsolidtumorsinbothadultsandchildren.
用途:抗肿瘤。
蛋白酪氨酸激酶